Bentham Science Logo

Track Your Manuscript:

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 1

Antitumor Activities of Interleukin-27 on Melanoma

, 10(1): 41 - 46

Hiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, Mingli Xu, Izuru Mizoguchi, Takayuki Yoshimoto and Chikako Nishigori

DOI: 10.2174/187153010790827920

The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches

, 10(1): 71 - 82

Benoit Stijlemans, Ann Vankrunkelsven, Guy Caljon, Viki Bockstal, Martin Guilliams, Tom Bosschaerts, Alain Beschin, Geert Raes, Stefan Magez and Patrick De Baetselier

DOI: 10.2174/187153010790827966


Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”

View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations

Society Name: The official Journal of Associazione Medici Endocrinologi


Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog